Literature DB >> 4027483

Application of the operational model of agonism to establish conditions when functional antagonism may be used to estimate agonist dissociation constants.

P Leff, G R Martin, J M Morse.   

Abstract

The operational model of agonism (Black & Leff, 1983) has been used to analyse comparatively functional antagonism and irreversible antagonism as methods for estimating agonist dissociation constants (KAs). A general condition is established in terms of the model parameters which defines the type of experimental interventions at the receptor and the post-receptor level that allow valid KA estimation. It is shown that functional antagonism and other post-receptor interventions may produce changes in agonist-concentration effect curves which are qualitatively indistinguishable but quantitatively distinct, from those produced by irreversible antagonism. Experimental data obtained with the guinea-pig tracheal strip preparation are in keeping with the theoretical predictions and show how studies using functional antagonism may overestimate agonist affinity. In general, functional antagonism, unlike irreversible antagonism, is in principle an unreliable method for quantifying agonism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027483      PMCID: PMC1916522          DOI: 10.1111/j.1476-5381.1985.tb10561.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  On spare beta-adrenoceptors of inotropic effect of catecholamines in kitten ventricle.

Authors:  A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-11       Impact factor: 3.000

2.  On the use of functional antagonism to estimate dissociation constants for beta adrenergic receptor agonists in isolated guinea-pig trachea.

Authors:  C K Buckner; R K Saini
Journal:  J Pharmacol Exp Ther       Date:  1975-09       Impact factor: 4.030

3.  Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes.

Authors:  K P Minneman; L R Hegstrand; P B Molinoff
Journal:  Mol Pharmacol       Date:  1979-07       Impact factor: 4.436

4.  The effects of 6-hydroxydopamine and guanethidine on peripheral adrenergic nerves in the guinea pig.

Authors:  S R O'Donnell; N Saar
Journal:  Eur J Pharmacol       Date:  1974-10       Impact factor: 4.432

5.  The influence of calcium on the activity of full and partial muscarinic agonists.

Authors:  J M Gião; T Rico
Journal:  Eur J Pharmacol       Date:  1971-01       Impact factor: 4.432

6.  The zig-zag tracheal strip.

Authors:  J Emmerson; D Mackay
Journal:  J Pharm Pharmacol       Date:  1979-11       Impact factor: 3.765

7.  The model of functional interaction. I. Development and first check of a new model of functional synergism and antagonism.

Authors:  F G van den Brink
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

8.  The affinity and efficacy of onium salts on the frog rectus abdominis.

Authors:  R B Barlow; N C Scott; R P Stephenson
Journal:  Br J Pharmacol Chemother       Date:  1967-09

9.  Contractile responses of the guinea-pig trachea in vitro: modification by prostaglandin synthesis-inhibiting drugs.

Authors:  J Orehek; J S Douglas; A Bouhuys
Journal:  J Pharmacol Exp Ther       Date:  1975-09       Impact factor: 4.030

10.  Functional antagonism as a means of determining dissociation constants and relative efficacies of sympathomimetic amines in guinea-pig isolated atria.

Authors:  K J Broadley; C D Nicholson
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

View more
  17 in total

1.  Pharmacological analysis of the calcium-dependence of mu-receptor agonism.

Authors:  I G Dougall; P Leff
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

2.  Pharmacological analysis of the muscarinic receptors involved when McN-A 343 stimulates acid secretion in the mouse isolated stomach.

Authors:  J W Black; N P Shankley
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

3.  Pharmacological analysis of the interaction between Bay K 8644 and 5-HT in rabbit aorta.

Authors:  V J Barrett; P Leff; G R Martin; P J Richardson
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

4.  Affinities of full agonists for cardiac beta-adrenoceptors calculated by use of in vitro desensitization.

Authors:  M L Herepath; K J Broadley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

5.  Nobel lecture in physiology or medicine--1988. Drugs from emasculated hormones: the principle of syntopic antagonism.

Authors:  J Black
Journal:  In Vitro Cell Dev Biol       Date:  1989-04

6.  Desensitization and functional antagonism by beta-adrenoceptor and muscarinic receptor agonists, respectively: a comparison with receptor alkylation for calculation of apparent agonist affinity.

Authors:  R M Eglen; W W Montgomery; R L Whiting
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

7.  Modelling the changes induced by chronic desipramine treatment on the factors governing the agonism at prejunctional alpha 2-adrenoceptors.

Authors:  J Sallés; J Giraldo; E Vila; A Badia
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

8.  Interactions between responses mediated by activation of adenosine A2 receptors and alpha 1-adrenoceptors in the rabbit isolated aorta.

Authors:  H L Wiener; G P Thalody; S Maayani
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

9.  Interconversion into a low active state protects vascular 5-HT2-receptors against irreversible antagonism by phenoxybenzamine.

Authors:  M Frenken; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

10.  Determination of KA values by controlled receptor expression in Xenopus oocytes.

Authors:  H Murakoshi; K Nunoki; K Ishii; N Taira
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.